{"gene":"CD79A","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1988,"finding":"The mb-1 gene (encoding Igα/CD79A) was identified as a B lymphocyte lineage-restricted gene encoding a putative membrane glycoprotein with a leader sequence, extracellular domain, transmembrane portion, and intracellular domain. Antibodies against the mb-1 fusion protein stained pre-B and mature B cell lines on their surface but not T cell lines or fibroblasts, establishing its B-cell-specific surface expression.","method":"cDNA cloning, Northern blot, antibody staining of cell lines","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — original gene identification with protein expression validation, highly cited foundational paper","pmids":["2463161"],"is_preprint":false},{"year":1990,"finding":"The murine mb-1 gene structure was characterized: five exons encoding signal peptide, extracellular, transmembrane, and cytoplasmic domains. A B cell-specific DNase I-hypersensitive site was identified in the 3'-flanking region, indicating its involvement in B cell-specific expression of mb-1.","method":"Genomic DNA cloning, Southern blot, DNase I hypersensitivity assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 — direct structural characterization of the gene with functional regulatory element identification","pmids":["2358676"],"is_preprint":false},{"year":1991,"finding":"A common Igα (CD79A) chain associates with all five immunoglobulin classes (IgM, IgD, IgG, IgA, IgE) at the B cell surface. Just two proteins—the alpha and beta associated chains—are sufficient to reconstitute an IgM surface receptor in fibroblasts, demonstrating that the Igα/Igβ heterodimer is the minimal signaling unit of the BCR.","method":"Reconstitution in fibroblasts, co-immunoprecipitation, surface receptor expression","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution experiment in non-B cells establishing sufficiency; foundational paper","pmids":["1881434"],"is_preprint":false},{"year":1992,"finding":"The 72-kDa protein-tyrosine kinase PTK72 (Syk) is physically associated with the B cell antigen receptor via MB-1 (Igα/CD79A). PTK72 co-immunoprecipitates with sIgM, phosphorylates MB-1 in immune complexes, and its enzymatic activity is activated upon cross-linking of sIgM, placing Syk as an Igα-associated kinase that is activated downstream of BCR engagement.","method":"Co-immunoprecipitation, in vitro kinase assay, peptide mapping, reimmunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal co-IP, in vitro phosphorylation, and activation assay in a single study","pmids":["1569106"],"is_preprint":false},{"year":1992,"finding":"Cross-linking of the B cell antigen receptor results in rapid tyrosine phosphorylation of substrate proteins, and the BCR is a multicomponent complex in which membrane-bound Ig is noncovalently associated with an Igα/Igβ heterodimer, establishing the structural basis of BCR-mediated signaling analogous to the T cell receptor/CD3 complex.","method":"Biochemical co-immunoprecipitation, tyrosine phosphorylation assays","journal":"Annual review of immunology","confidence":"High","confidence_rationale":"Tier 2 — synthesis of multiple experimental findings; highly cited foundational review summarizing demonstrated mechanisms","pmids":["1591006"],"is_preprint":false},{"year":1994,"finding":"CD5 is physically associated with the B cell antigen receptor complex including Igα (CD79A) on human B cells, and CD5 serves as a substrate for BCR-induced tyrosine kinase activity, indicating that CD5+ B cells have a unique capacity to modulate BCR signals.","method":"Co-immunoprecipitation, tyrosine phosphorylation assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP study demonstrating BCR-CD5 association","pmids":["7512031"],"is_preprint":false},{"year":1995,"finding":"PTP1C (SHP-1) constitutively associates with the resting BCR complex through co-precipitation with BCR components including Igα. PTP1C specifically dephosphorylates a 35-kDa BCR-associated protein likely representing Igα, and dissociates from the activated BCR complex after receptor engagement, revealing SHP-1 as a phosphatase that regulates the tyrosine phosphorylation state of Igα in resting B cells.","method":"Co-immunoprecipitation, phosphatase activity assay, anti-PTP1C antibody depletion","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-IP, phosphatase activity, antibody depletion) in motheaten mice and cell lines","pmids":["7539038"],"is_preprint":false},{"year":1995,"finding":"Both Syk SH2 domains are required for recruitment of Syk to tyrosine-phosphorylated Igα and Igβ ITAMs, and this recruitment is necessary for BCR-mediated Syk and PLCγ2 phosphorylation, IP3 release, and Ca2+ mobilization. The Syk autophosphorylation site Y518/Y519 is required for signal transduction but not for ITAM binding, indicating that ITAM binding precedes and is required for Syk autophosphorylation.","method":"Syk knockout B cells reconstituted with Syk mutants, co-immunoprecipitation, calcium flux assay, PLC-γ2 phosphorylation","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — genetic reconstitution with structure-function mutagenesis in knockout cells","pmids":["7500027"],"is_preprint":false},{"year":1995,"finding":"Novel variants of mb-1 (CD79A) transcripts generated by alternative mRNA splicing were identified. The variant proteins conserve transmembrane and cytoplasmic portions but lack part of the extracellular domain containing cysteine residues required for disulfide bonds. Transfection studies revealed that variant mb-1 does not contribute to BCR surface expression. B cell activation with anti-IgM, LPS, or IL-4 significantly increases the amount of variant mb-1 transcripts.","method":"cDNA cloning, transfection, BCR surface expression assay, Northern blot","journal":"Immunology letters","confidence":"Medium","confidence_rationale":"Tier 2 — functional demonstration by transfection that splice variant cannot form BCR","pmids":["8747711"],"is_preprint":false},{"year":1997,"finding":"The Igα/Igβ heterodimer is present on the surface of μ-negative proB cell lines in association with calnexin. Cross-linking of Igβ on RAG-2-deficient proB cells induces rapid tyrosine phosphorylation of Igα as well as Syk, PI3-kinase, Vav, SLP-76, and ERK (but not JNK or p38), and induces proB cell differentiation to the small preB cell stage, demonstrating that the Igα/Igβ heterodimer is signaling-competent before μ heavy chain expression.","method":"Flow cytometry, anti-Igβ cross-linking in RAG-2-deficient mice, tyrosine phosphorylation analysis, in vivo mAb treatment","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro experiments with defined signaling cascade and developmental readout","pmids":["9354476"],"is_preprint":false},{"year":1998,"finding":"Phosphorylation of the two ITAM tyrosines of CD79a (Igα) is asymmetrical: >80% of phosphorylation occurs on the N-terminal tyrosine (Y-E-G-L). Only the N-terminal ITAM tyrosine of CD79a is required for ligand-mediated phosphorylation of the receptor and downstream substrates (p62, p110, Shc), and for Ca2+ mobilization. Both tyrosines are required for Syk phosphorylation. CD79b shows greater dependence on both tyrosines compared to CD79a.","method":"MHC class II chimeric receptor system, ITAM tyrosine-to-phenylalanine mutagenesis, phosphorylation assays, Ca2+ mobilization","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with multiple downstream readouts in defined chimeric receptor system","pmids":["9531288"],"is_preprint":false},{"year":1999,"finding":"A homozygous splice defect in Igα (CD79A) in a human patient causes a complete block in B-cell development at the pro-B to pre-B transition, equivalent to that seen in μ heavy chain deficiency, establishing CD79A mutations as a cause of agammaglobulinemia. The block occurs after V-DJ rearrangement, suggesting Igα is not critical for development until expressed as part of the pre-BCR with μ heavy chain.","method":"Human patient genetic analysis, immunofluorescence of bone marrow B-cell developmental stages, V-DJ sequencing","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — human loss-of-function genetics with defined cellular phenotype and comparison to μ-chain deficiency","pmids":["10525050"],"is_preprint":false},{"year":1999,"finding":"Truncation of the Igα intracellular cytoplasmic domain (mb-1 Δc/Δc mice) results in constitutive signaling of the antigen receptor complex on immature B cells, causing activation and loss of transitional IgMhigh IgDlow B cells, thereby accounting for the paucity of mature peripheral B cells. This demonstrates a negative regulatory role for the Igα cytoplasmic tail during B cell development.","method":"mb-1 cytoplasmic tail truncation knock-in mouse, flow cytometry of B-cell developmental stages, analysis of immature B cell activation","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — genetic knock-in mouse with defined cellular phenotype and mechanistic interpretation","pmids":["10591178"],"is_preprint":false},{"year":2000,"finding":"All serine and threonine residues in the Igα cytoplasmic tail were mutated to alanine/valine, resulting in stronger tyrosine phosphorylation of Igα and increased BCR signaling upon stimulation. This establishes that serine/threonine kinases negatively regulate ITAM-mediated signal transduction from the BCR by phosphorylating the Igα tail.","method":"Site-directed mutagenesis of all Ser/Thr residues, single-chain Fv/Igα chimera and full BCR context, tyrosine phosphorylation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis in two expression contexts with signaling readout","pmids":["10900006"],"is_preprint":false},{"year":2001,"finding":"SLP-65 (BLNK) directly associates with the BCR signaling subunit via the SH2 domain of SLP-65 binding to phosphorylated Igα tyrosine Y204, which is located outside the ITAM. This identifies a non-ITAM phosphorylation site on Igα as a transmembrane adaptor function coupling the BCR to distal signaling pathways.","method":"Co-immunoprecipitation after B cell stimulation, SH2-phosphotyrosine interaction mapping","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct interaction demonstrated by co-IP with domain-level specificity","pmids":["11449366"],"is_preprint":false},{"year":2002,"finding":"BLNK is directly recruited to Igα via non-ITAM tyrosines Y176 and Y204. Using chimeric receptors with wild-type and mutant Igα cytoplasmic tails, Y204 was shown to bind BLNK directly, and fusion of BLNK to mutated Igα reconstituted downstream signaling. BCR ligation induces Y204 phosphorylation and BLNK recruitment, establishing the molecular mechanism by which Igα couples Syk activation to BLNK-dependent pathways.","method":"Chimeric receptor mutagenesis, direct binding assays, reconstitution of signaling in mutant-Igα expressing cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and direct binding, multiple orthogonal methods","pmids":["11909947"],"is_preprint":false},{"year":2003,"finding":"The mb-1 (Igα/CD79A) gene undergoes somatic hypermutation (SHM) in germinal center B cells at frequencies similar to other non-Ig genes but lower than Ig genes. Mutations in mb-1 occur as single nucleotide substitutions targeted to hotspots, with a characteristic distribution pattern across the gene, identifying CD79A as a target of the SHM machinery during B cell maturation.","method":"Sequencing of mb-1 genes from GC-derived malignant B cell lines and normal peripheral B cells, SHM hotspot analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct sequencing across multiple normal and malignant B cell samples with statistical analysis","pmids":["12651942"],"is_preprint":false},{"year":2003,"finding":"BAP29 and BAP31 ER-resident membrane proteins bind to membrane-bound IgD in the ER and retain it there; this retention is distinct from and competitive with Igα/Igβ binding to mIgD. Only a minor fraction of intracellular mIgD is associated with BAP29/BAP31 complexes. Coexpression of BAP29/BAP31 prevented aberrant surface transport of mIgD in the absence of Igα/Igβ, establishing that BAP complexes function as ER retention proteins for mIg that is not assembled with Igα/Igβ.","method":"Blue native PAGE, co-immunoprecipitation, Drosophila S2 cell surface expression, chimeric mIgD constructs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including reconstitution in non-B cells","pmids":["12886015"],"is_preprint":false},{"year":2004,"finding":"The cytoplasmic domain of Igα (CD79A) forms stable dimers and tetramers in solution even below 10 μM, in contrast to other ITAM-containing proteins. Circular dichroic analysis reveals that the Igα cytoplasmic domain lacks stable ordered structure (random-coil-like), and phosphorylation does not significantly alter oligomerization behavior, suggesting a structural basis for transmembrane signal initiation.","method":"Purified recombinant Igα cytoplasmic domain, biophysical assays (sedimentation, CD spectroscopy), NMR, phosphorylation analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple biophysical methods with purified recombinant protein","pmids":["14967045"],"is_preprint":false},{"year":2004,"finding":"Basal signaling through non-aggregated Igα/Igβ complexes targeted to the inner plasma membrane leaflet of primary pro-B cells is sufficient to promote pre-BCR-dependent processes: enhanced proliferation at low IL-7, suppression of VH(D)JH recombination, and induction of κ light chain recombination and cytoplasmic κ expression. This demonstrates that pre-BCR aggregation is not required for pre-BCR function and that tonic Igα/Igβ signals coordinate developmental checkpoints.","method":"Membrane-targeted cytoplasmic Igα/Igβ construct in primary pro-B cells, IL-7 proliferation assay, VDJ/κ recombination analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic reconstitution in primary cells with multiple developmental readouts","pmids":["15240688"],"is_preprint":false},{"year":2004,"finding":"The cytoplasmic domain of avian Igα (CD79A ortholog) efficiently supports B-cell development in precursors lacking endogenous sIg when expressed as a chimeric CD8α-Igα(cyt) receptor, whereas an equivalent chimeric receptor containing the Igβ cytoplasmic domain actively inhibited B-cell development. This establishes functionally distinct roles for the Igα and Igβ cytoplasmic domains in B-cell development.","method":"Retroviral gene transfer of chimeric receptor constructs into chicken B-cell precursors in vivo, B-cell development assay","journal":"Immunological reviews","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic reconstitution with defined developmental readout","pmids":["14962183"],"is_preprint":false},{"year":2006,"finding":"The mb-1 gene (encoding Igα/CD79A) was used as a host locus for Cre recombinase to generate mb1-cre mice. Integration of humanized Cre into the mb1 locus results in extraordinarily efficient recombination of loxP sites exclusively in the B cell lineage beginning at the very early pro-B cell stage, confirming that mb-1/CD79A expression initiates at the earliest B-cell progenitor stage.","method":"Knock-in of humanized Cre into mb1 locus, reporter gene analysis across B-cell developmental stages","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic knock-in with multiple reporter validations across stages","pmids":["16940357"],"is_preprint":false},{"year":2007,"finding":"The Igα ITAM is required for efficient pre-B cell differentiation but not for pre-BCR-induced proliferation. Reconstitution of Igα tyrosine mutants in SLP-65/Igα double-deficient pre-B cells showed comparable pre-BCR surface expression but different signaling (tyrosine phosphorylation, calcium flux); the ITAM tyrosines and Y204 are required for efficient calcium flux and differentiation. Additionally, the pre-BCR modulates IL-7 receptor surface expression, increasing IL-7 sensitivity.","method":"Igα mutant reconstitution in double-deficient pre-B cells, proliferation and differentiation assays, calcium flux, flow cytometry","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 — systematic mutagenesis with functional reconstitution and multiple readouts","pmids":["17163454"],"is_preprint":false},{"year":2007,"finding":"Anti-CD79b antibody-drug conjugates (ADCs) are trafficked to the lysosomal-like MHC class II-positive compartment (MIIC) following BCR internalization. Anti-CD79b ADCs with stable linkers were effective in killing NHL cell lines in vitro and in xenograft models. Anti-CD79b ADCs downregulated surface BCR, while anti-CD79a ADCs were less effective, suggesting differential intracellular trafficking between CD79a and CD79b upon BCR engagement.","method":"ADC cytotoxicity assays in NHL cell lines, xenograft mouse models, confocal microscopy of lysosomal trafficking, BCR downregulation assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct trafficking/localization experiments with functional consequence, but CD79a role is comparative/secondary","pmids":["17374736"],"is_preprint":false},{"year":2011,"finding":"CD79A/CD79B mutations in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) correlate with sensitivity to the PKC inhibitor sotrastaurin (STN). PKC inhibition in CD79A/B-mutant cells blocks NF-κB pathway activity, induces G1-phase cell-cycle arrest and/or cell death, and produces significant antitumor effects in a xenograft model, establishing that CD79A mutations drive constitutive NF-κB activation via PKC-dependent BCR signaling.","method":"Cell line sensitivity profiling, NF-κB pathway analysis, cell cycle assay, xenograft mouse model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (biochemical, cellular, in vivo) with genetic stratification","pmids":["21324920"],"is_preprint":false},{"year":2021,"finding":"A composite CD79A/CD40 co-stimulatory endodomain incorporated into CD19-CAR T cells (CD19.79a.40z) induces higher NF-κB and p38 activity upon CD19 antigen exposure compared to CD28 or 4-1BB co-stimulatory domains. CD19.79a.40z CAR-T cells exhibit robust T cell proliferation independent of exogenous IL-2, sustained tumor suppression in co-culture, and superior anti-tumor activity with enhanced in vivo CAR-T cell proliferation in Raji-inoculated mice, demonstrating that the CD79A intracellular domain can activate NF-κB signaling and enhance T cell function as a co-stimulatory module.","method":"CAR-T cell co-culture cytotoxicity assays, NF-κB/p38 reporter assays, in vitro proliferation, Raji xenograft mouse model","journal":"Molecular therapy","confidence":"High","confidence_rationale":"Tier 2 — multiple in vitro and in vivo methods with mechanistic NF-κB pathway analysis","pmids":["33940156"],"is_preprint":false},{"year":2023,"finding":"CD79a/CD79b mediate BCR signal initiation and transduction through ITAMs, with post-translational modifications (phosphorylation of ITAM tyrosines, serine/threonine phosphorylation) regulating signaling. CD79A/CD79B mutations in lymphoid neoplasms, particularly ABC-DLBCL, cause constitutive BCR signaling through chronic active BCR signaling. CD79a functions as a signal integrator within the BCR complex, with its non-ITAM tyrosines (Y176, Y204) serving as adaptor sites for BLNK/SLP-65 recruitment, and its cytoplasmic tail regulating signal amplitude through serine/threonine phosphorylation.","method":"Review synthesizing ITAM mutagenesis, structural, interactome, and lymphoma mutation studies","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 3 — comprehensive mechanistic review, no new primary data; supports existing findings","pmids":["38203179"],"is_preprint":false}],"current_model":"CD79A (Igα/mb-1) is a B-cell-specific transmembrane protein that forms an obligate Igα/Igβ heterodimer constitutively associated with all classes of membrane-bound immunoglobulin to form the B cell antigen receptor (BCR); upon BCR engagement, Igα ITAM tyrosines are asymmetrically phosphorylated (predominantly at the N-terminal tyrosine) by Src-family kinases and recruit Syk via its dual SH2 domains, while the non-ITAM tyrosine Y204 serves as a direct docking site for the adaptor BLNK/SLP-65 to couple Syk to downstream Ca2+ and NF-κB signaling; the Igα cytoplasmic tail additionally undergoes serine/threonine phosphorylation that negatively regulates ITAM-mediated signaling, and the tail forms stable oligomers in solution; basal tonic Igα/Igβ signaling drives pre-BCR developmental checkpoints including allelic exclusion and light chain recombination without requiring receptor aggregation, while loss-of-function mutations in CD79A cause a complete block in B-cell development at the pro-B to pre-B transition (human agammaglobulinemia), and gain-of-function/chronic-active mutations in the ITAM region drive constitutive NF-κB activation in ABC-DLBCL."},"narrative":{"teleology":[{"year":1988,"claim":"Identification of mb-1 as a B-cell-specific surface glycoprotein gene resolved the question of which lineage-restricted transmembrane molecules might couple surface immunoglobulin to intracellular signaling.","evidence":"cDNA cloning with antibody staining of pre-B and mature B cell lines vs. T cells and fibroblasts","pmids":["2463161"],"confidence":"High","gaps":["No signaling function yet demonstrated","Heterodimeric partner (Igβ) not yet identified in this study"]},{"year":1991,"claim":"Reconstitution of surface IgM expression in fibroblasts with only Igα and Igβ established that this heterodimer is the minimal signaling unit of the BCR and associates with all five immunoglobulin isotypes, resolving the composition of the BCR signaling module.","evidence":"Fibroblast reconstitution with co-immunoprecipitation across IgM/IgD/IgG/IgA/IgE","pmids":["1881434"],"confidence":"High","gaps":["Kinase(s) responsible for signal initiation not yet identified","No structural data on Igα/Igβ heterodimer"]},{"year":1992,"claim":"Discovery that the tyrosine kinase Syk physically associates with Igα and is activated upon BCR cross-linking identified the first kinase in the Igα proximal signaling cascade, establishing a direct kinase–ITAM connection.","evidence":"Reciprocal co-immunoprecipitation, in vitro kinase assay, and peptide mapping in B cell lines","pmids":["1569106"],"confidence":"High","gaps":["Which ITAM tyrosines are required for Syk binding not yet resolved","Downstream substrates of Syk in this context unknown"]},{"year":1995,"claim":"Demonstration that both Syk SH2 domains are required for ITAM binding and that ITAM recruitment precedes Syk autophosphorylation and Ca²⁺ mobilization established the ordered activation mechanism of BCR proximal signaling, while parallel work showed SHP-1 constitutively associates with resting BCR to restrain Igα phosphorylation.","evidence":"Syk-knockout B cells reconstituted with SH2/kinase mutants; SHP-1 co-IP with phosphatase activity assays in motheaten mice","pmids":["7500027","7539038"],"confidence":"High","gaps":["Structural basis of dual SH2–ITAM engagement not resolved","Identity of kinase initially phosphorylating the ITAM not established"]},{"year":1997,"claim":"Finding that the Igα/Igβ heterodimer is expressed on pro-B cells before μ heavy chain and can signal through Syk/PI3K/Vav to drive differentiation revealed that Igα has signaling functions independent of complete BCR assembly.","evidence":"Anti-Igβ cross-linking on RAG-2-deficient pro-B cells with phosphorylation cascade analysis and in vivo differentiation","pmids":["9354476"],"confidence":"High","gaps":["Whether Igα or Igβ tail is the dominant contributor to these pre-BCR-independent signals not resolved"]},{"year":1998,"claim":"Systematic ITAM tyrosine mutagenesis revealed that phosphorylation of the Igα ITAM is asymmetric, with the N-terminal tyrosine (YEGL) accounting for >80% of phosphorylation and being sufficient for most downstream signaling except full Syk activation, which requires both tyrosines.","evidence":"MHC class II chimeric receptor system with Y→F point mutations, phosphorylation assays, Ca²⁺ mobilization","pmids":["9531288"],"confidence":"High","gaps":["Structural explanation for asymmetric phosphorylation unknown","Kinase selectivity for N- vs. C-terminal ITAM tyrosine not identified"]},{"year":1999,"claim":"A human homozygous CD79A splice mutation causing complete B-cell developmental arrest at the pro-B/pre-B transition established CD79A as a causative gene for agammaglobulinemia, while truncation of the Igα cytoplasmic tail in mice paradoxically caused constitutive BCR signaling and loss of transitional B cells, revealing a dual role as both activator and negative regulator.","evidence":"Human patient genetics with bone marrow staging; mb-1Δc/Δc knock-in mice with flow cytometric B-cell profiling","pmids":["10525050","10591178"],"confidence":"High","gaps":["Mechanism by which tail truncation causes constitutive signaling not molecularly defined","Additional human CD79A mutations not yet cataloged"]},{"year":2000,"claim":"Mutation of all serine/threonine residues in the Igα tail to alanine/valine augmented ITAM tyrosine phosphorylation, identifying Ser/Thr phosphorylation as a dedicated negative-feedback mechanism that attenuates BCR signal amplitude.","evidence":"Comprehensive S/T→A/V mutagenesis in single-chain Fv/Igα chimera and full BCR, tyrosine phosphorylation readout","pmids":["10900006"],"confidence":"High","gaps":["Identity of the Ser/Thr kinase(s) responsible not determined","Stoichiometry and temporal order of Ser/Thr vs. Tyr phosphorylation unclear"]},{"year":2001,"claim":"Identification of Y204 as a non-ITAM phosphotyrosine docking site for the SH2 domain of BLNK/SLP-65 revealed how Igα couples proximal Syk activation to distal Ca²⁺ and NF-κB pathways, expanding Igα function beyond classical ITAM signaling.","evidence":"Co-immunoprecipitation after BCR stimulation with SH2–phosphotyrosine mapping; confirmed by chimeric receptor mutagenesis and BLNK fusion reconstitution","pmids":["11449366","11909947"],"confidence":"High","gaps":["Whether Y176 also recruits BLNK independently of Y204 not fully resolved","No crystal structure of Igα tail–BLNK SH2 complex"]},{"year":2004,"claim":"Tonic (non-aggregated) Igα/Igβ signals targeted to the inner plasma membrane suffice to drive pre-BCR-dependent developmental checkpoints including κ light chain recombination, establishing that pre-BCR aggregation is dispensable and basal signaling coordinates allelic exclusion.","evidence":"Membrane-targeted cytoplasmic Igα/Igβ construct in primary pro-B cells with IL-7 proliferation, VDJ, and κ recombination readouts","pmids":["15240688"],"confidence":"High","gaps":["Precise signaling threshold distinguishing tonic from activated BCR signaling unknown","Which downstream pathways are differentially engaged by tonic vs. aggregated signals not resolved"]},{"year":2011,"claim":"CD79A ITAM mutations in ABC-DLBCL were linked to constitutive NF-κB activation and sensitivity to PKC inhibition, establishing a pathogenic gain-of-function mechanism and revealing that oncogenic BCR signaling requires PKC-dependent NF-κB transduction.","evidence":"Cell line sensitivity profiling, NF-κB pathway analysis, cell cycle arrest assays, and xenograft models stratified by CD79A/B mutation status","pmids":["21324920"],"confidence":"High","gaps":["Whether CD79A and CD79B mutations are functionally equivalent or additive not fully dissected","Mechanism by which ITAM mutations escape negative regulation not structurally resolved"]},{"year":null,"claim":"Key unresolved questions include the high-resolution structure of the Igα/Igβ heterodimer and its interface with membrane immunoglobulin, the identity of the Ser/Thr kinases that negatively regulate the Igα tail, and the structural basis for asymmetric ITAM tyrosine phosphorylation.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No atomic-resolution structure of the complete BCR signaling complex","Ser/Thr kinase(s) targeting the Igα cytoplasmic tail remain unidentified","Mechanism of Igα cytoplasmic domain oligomerization and its functional significance in vivo not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[14,15,25]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,4,10,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,9,19]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,7,10,14,15,24,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,10,13,24,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,11,12,19,20,22]}],"complexes":["B-cell antigen receptor (BCR) complex"],"partners":["CD79B","SYK","PTPN6","BLNK","CD5","BCAP31"],"other_free_text":[]},"mechanistic_narrative":"CD79A (Igα/mb-1) is a B-cell-lineage-restricted transmembrane glycoprotein that heterodimerizes with CD79B (Igβ) to form the obligate signaling subunit of the B-cell antigen receptor (BCR), associating with all five classes of membrane-bound immunoglobulin to transduce antigen-dependent and tonic signals essential for B-cell development and activation [PMID:1881434, PMID:9354476]. Upon BCR engagement, Src-family kinases asymmetrically phosphorylate the Igα ITAM — predominantly at the N-terminal tyrosine — enabling dual-SH2-domain recruitment and activation of Syk, which in turn drives PLCγ2/Ca²⁺ mobilization, while a non-ITAM tyrosine (Y204) directly recruits the adaptor BLNK/SLP-65 to couple Syk to downstream NF-κB and MAPK pathways [PMID:9531288, PMID:11909947, PMID:7500027]. Serine/threonine phosphorylation of the Igα cytoplasmic tail negatively regulates ITAM signaling amplitude, and truncation of this tail causes constitutive signaling and developmental arrest of transitional B cells [PMID:10900006, PMID:10591178]. Homozygous loss-of-function mutations in CD79A cause human agammaglobulinemia with a complete block at the pro-B to pre-B transition, whereas gain-of-function ITAM mutations in ABC-DLBCL drive constitutive NF-κB activation [PMID:10525050, PMID:21324920]."},"prefetch_data":{"uniprot":{"accession":"P11912","full_name":"B-cell antigen receptor complex-associated protein alpha chain","aliases":["Ig-alpha","MB-1 membrane glycoprotein","Membrane-bound immunoglobulin-associated protein","Surface IgM-associated protein"],"length_aa":226,"mass_kda":25.0,"function":"Required in cooperation with CD79B for initiation of the signal transduction cascade activated by binding of antigen to the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Also required for BCR surface expression and for efficient differentiation of pro- and pre-B-cells. Stimulates SYK autophosphorylation and activation. Binds to BLNK, bringing BLNK into proximity with SYK and allowing SYK to phosphorylate BLNK. Also interacts with and increases activity of some Src-family tyrosine kinases. Represses BCR signaling during development of immature B-cells","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P11912/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD79A","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD79A","total_profiled":1310},"omim":[{"mim_id":"613501","title":"AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3","url":"https://www.omim.org/entry/613501"},{"mim_id":"612692","title":"AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6","url":"https://www.omim.org/entry/612692"},{"mim_id":"605300","title":"SH2B ADAPTOR PROTEIN 2; SH2B2","url":"https://www.omim.org/entry/605300"},{"mim_id":"605027","title":"LYMPHOMA, NON-HODGKIN, FAMILIAL","url":"https://www.omim.org/entry/605027"},{"mim_id":"604762","title":"SWITCH-ASSOCIATED PROTEIN 70","url":"https://www.omim.org/entry/604762"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":157.7},{"tissue":"lymphoid tissue","ntpm":510.4}],"url":"https://www.proteinatlas.org/search/CD79A"},"hgnc":{"alias_symbol":["MB-1","Ig-alpha","MB1","IGAlpha"],"prev_symbol":["IGA"]},"alphafold":{"accession":"P11912","domains":[{"cath_id":"2.60.40.10","chopping":"42-127","consensus_level":"high","plddt":89.6981,"start":42,"end":127},{"cath_id":"1.20.5","chopping":"132-187","consensus_level":"medium","plddt":84.4534,"start":132,"end":187}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11912","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11912-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11912-F1-predicted_aligned_error_v6.png","plddt_mean":77.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD79A","jax_strain_url":"https://www.jax.org/strain/search?query=CD79A"},"sequence":{"accession":"P11912","fasta_url":"https://rest.uniprot.org/uniprotkb/P11912.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11912/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11912"}},"corpus_meta":[{"pmid":"21975936","id":"PMC_21975936","title":"Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.","date":"2011","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21975936","citation_count":914,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21949093","id":"PMC_21949093","title":"The pathophysiology of IgA nephropathy.","date":"2011","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/21949093","citation_count":681,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16940357","id":"PMC_16940357","title":"Testing gene function early in the B cell lineage in mb1-cre mice.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16940357","citation_count":497,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12524384","id":"PMC_12524384","title":"IgA Fc receptors.","date":"2001","source":"Annual review of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12524384","citation_count":389,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20101521","id":"PMC_20101521","title":"Selective IgA deficiency.","date":"2010","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20101521","citation_count":362,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4160397","id":"PMC_4160397","title":"The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva.","date":"1966","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/4160397","citation_count":319,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11576875","id":"PMC_11576875","title":"Predicting progression in IgA nephropathy.","date":"2001","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/11576875","citation_count":291,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30134201","id":"PMC_30134201","title":"IgA Responses to Microbiota.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30134201","citation_count":264,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11274926","id":"PMC_11274926","title":"IgA and the IgA Fc receptor.","date":"2001","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11274926","citation_count":221,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3871459","id":"PMC_3871459","title":"Jacalin: an IgA-binding lectin.","date":"1985","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/3871459","citation_count":215,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31817406","id":"PMC_31817406","title":"IgA: Structure, Function, and Developability.","date":"2019","source":"Antibodies (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/31817406","citation_count":195,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22430056","id":"PMC_22430056","title":"Pathogenesis of IgA nephropathy.","date":"2012","source":"Nature reviews. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/22430056","citation_count":184,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24892706","id":"PMC_24892706","title":"The genetics and immunobiology of IgA nephropathy.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24892706","citation_count":174,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38036542","id":"PMC_38036542","title":"IgA nephropathy.","date":"2023","source":"Nature reviews. Disease primers","url":"https://pubmed.ncbi.nlm.nih.gov/38036542","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7632952","id":"PMC_7632952","title":"CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7632952","citation_count":151,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10525050","id":"PMC_10525050","title":"Mutations in Igalpha (CD79a) result in a complete block in B-cell development.","date":"1999","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10525050","citation_count":147,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22539830","id":"PMC_22539830","title":"Corticosteroid therapy in IgA nephropathy.","date":"2012","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/22539830","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3142256","id":"PMC_3142256","title":"The immunohistology of IgA nephropathy.","date":"1988","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/3142256","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34170395","id":"PMC_34170395","title":"IgA vasculitis.","date":"2021","source":"Seminars in immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/34170395","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34495361","id":"PMC_34495361","title":"Current treatment of IgA nephropathy.","date":"2021","source":"Seminars in immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/34495361","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16641928","id":"PMC_16641928","title":"Treatment of IgA nephropathy.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16641928","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12110007","id":"PMC_12110007","title":"Interactions of human mesangial cells with IgA and IgA-containing immune complexes.","date":"2002","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12110007","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25116102","id":"PMC_25116102","title":"IgA, IgA receptors, and their anti-inflammatory properties.","date":"2014","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25116102","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15156526","id":"PMC_15156526","title":"Pathogenesis of IgA nephropathy.","date":"2004","source":"Seminars in nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/15156526","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17119122","id":"PMC_17119122","title":"TACI regulates IgA production by APRIL in collaboration with HSPG.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17119122","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9354476","id":"PMC_9354476","title":"The Ig alpha/Igbeta heterodimer on mu-negative proB cells is competent for transducing signals to induce early B cell differentiation.","date":"1997","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9354476","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3367561","id":"PMC_3367561","title":"Proteinuria in IgA nephropathy.","date":"1988","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/3367561","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25483334","id":"PMC_25483334","title":"Re-thinking the functions of IgA(+) plasma cells.","date":"2014","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/25483334","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34379175","id":"PMC_34379175","title":"Complement activation in IgA nephropathy.","date":"2021","source":"Seminars in immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/34379175","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15492262","id":"PMC_15492262","title":"PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15492262","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1931006","id":"PMC_1931006","title":"IgA deficiency.","date":"1991","source":"Immunodeficiency reviews","url":"https://pubmed.ncbi.nlm.nih.gov/1931006","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9924428","id":"PMC_9924428","title":"Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.","date":"1998","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9924428","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3387443","id":"PMC_3387443","title":"Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3387443","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8196286","id":"PMC_8196286","title":"Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy.","date":"1994","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/8196286","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3486314","id":"PMC_3486314","title":"Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy.","date":"1986","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/3486314","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2358676","id":"PMC_2358676","title":"Structure of the murine mb-1 gene encoding a putative sIgM-associated molecule.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2358676","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3586493","id":"PMC_3586493","title":"Complement activation in IgA nephropathy.","date":"1987","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/3586493","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3173354","id":"PMC_3173354","title":"Activation of complement by human serum IgA, secretory IgA and IgA1 fragments.","date":"1988","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3173354","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19834792","id":"PMC_19834792","title":"Role of IgA and IgA fc receptors in inflammation.","date":"2009","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19834792","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1287121","id":"PMC_1287121","title":"Receptors for IgA on phagocytic cells.","date":"1992","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/1287121","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10912936","id":"PMC_10912936","title":"Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.","date":"2000","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/10912936","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6417473","id":"PMC_6417473","title":"Inhibition of microbial IgA proteases by human secretory IgA and serum.","date":"1983","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6417473","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24709842","id":"PMC_24709842","title":"MicroRNAs in IgA nephropathy.","date":"2014","source":"Nature reviews. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/24709842","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21679872","id":"PMC_21679872","title":"IgA pemphigus.","date":"2011","source":"Clinics in dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21679872","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12383768","id":"PMC_12383768","title":"Pathogenic significance of IgA receptor interactions in IgA nephropathy.","date":"2002","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12383768","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38203179","id":"PMC_38203179","title":"B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38203179","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26567162","id":"PMC_26567162","title":"Role of complement in IgA nephropathy.","date":"2015","source":"Journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/26567162","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16757497","id":"PMC_16757497","title":"IgA-containing immune complexes in the urine of IgA nephropathy patients.","date":"2006","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/16757497","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3055972","id":"PMC_3055972","title":"Activation of complement in IgA nephropathy.","date":"1988","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/3055972","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6228743","id":"PMC_6228743","title":"The role of IgA and IgG immune complexes in IgA nephropathy.","date":"1984","source":"Nephron","url":"https://pubmed.ncbi.nlm.nih.gov/6228743","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18222347","id":"PMC_18222347","title":"The role of secretory IgA and complement in IgA nephropathy.","date":"2008","source":"Seminars in nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/18222347","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37114051","id":"PMC_37114051","title":"Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37114051","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38053977","id":"PMC_38053977","title":"Targeting complement in IgA nephropathy.","date":"2023","source":"Clinical kidney journal","url":"https://pubmed.ncbi.nlm.nih.gov/38053977","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18222350","id":"PMC_18222350","title":"The glomerular response to IgA deposition in IgA nephropathy.","date":"2008","source":"Seminars in nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/18222350","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10986389","id":"PMC_10986389","title":"Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols.","date":"2000","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/10986389","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28293726","id":"PMC_28293726","title":"Inflammation in IgA nephropathy.","date":"2017","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/28293726","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10591178","id":"PMC_10591178","title":"A negative regulatory role for Ig-alpha during B cell development.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10591178","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2205751","id":"PMC_2205751","title":"Polymeric IgA and immune complex concentrations in IgA-related renal disease.","date":"1990","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/2205751","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26519703","id":"PMC_26519703","title":"Production, extraction and stabilization of lutein from microalga Chlorella sorokiniana MB-1.","date":"2015","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/26519703","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18838917","id":"PMC_18838917","title":"Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.","date":"2009","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/18838917","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10874883","id":"PMC_10874883","title":"Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.","date":"2000","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10874883","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11840384","id":"PMC_11840384","title":"CD44 expression in IgA nephropathy.","date":"2002","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/11840384","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20500772","id":"PMC_20500772","title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.","date":"2010","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20500772","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9341762","id":"PMC_9341762","title":"Size-dependent effect of IgA on the IgA Fc receptor (CD89).","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9341762","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10392257","id":"PMC_10392257","title":"Pathogenesis of IgA nephropathy.","date":"1999","source":"Annales de medecine interne","url":"https://pubmed.ncbi.nlm.nih.gov/10392257","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33940156","id":"PMC_33940156","title":"Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival.","date":"2021","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33940156","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23269075","id":"PMC_23269075","title":"IgA production and tonsillar focal infection in IgA nephropathy.","date":"2012","source":"Journal of clinical and experimental hematopathology : JCEH","url":"https://pubmed.ncbi.nlm.nih.gov/23269075","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39188719","id":"PMC_39188719","title":"Contemporary review of IgA nephropathy.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39188719","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12115880","id":"PMC_12115880","title":"Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias.","date":"2002","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12115880","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26572664","id":"PMC_26572664","title":"Role of IgA receptors in the pathogenesis of IgA nephropathy.","date":"2015","source":"Journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/26572664","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16005710","id":"PMC_16005710","title":"Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.","date":"2005","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16005710","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27469325","id":"PMC_27469325","title":"Scarcity of autoreactive human blood IgA+ memory B cells.","date":"2016","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27469325","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7622199","id":"PMC_7622199","title":"Homogenous IgA monomers, dimers, trimers and tetramers from the same IgA myeloma serum.","date":"1995","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/7622199","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32085673","id":"PMC_32085673","title":"Immunological Pattern in IgA Nephropathy.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32085673","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29178575","id":"PMC_29178575","title":"Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.","date":"2018","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/29178575","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35577505","id":"PMC_35577505","title":"Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy.","date":"2022","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35577505","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30629456","id":"PMC_30629456","title":"Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30629456","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12366855","id":"PMC_12366855","title":"Salivary IgA subclasses and bacteria-reactive IgA in patients with aggressive periodontitis.","date":"2002","source":"Journal of periodontal research","url":"https://pubmed.ncbi.nlm.nih.gov/12366855","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15752226","id":"PMC_15752226","title":"Mechanisms of tubulointerstitial injury in IgA nephropathy.","date":"2005","source":"Kidney international. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/15752226","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25116271","id":"PMC_25116271","title":"IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.","date":"2014","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25116271","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12768083","id":"PMC_12768083","title":"Inherited forms of IgA nephropathy.","date":"2003","source":"Journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/12768083","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21494642","id":"PMC_21494642","title":"Role of glomerular proteoglycans in IgA nephropathy.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21494642","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20606479","id":"PMC_20606479","title":"Oxidative stress in IgA nephropathy.","date":"2010","source":"Nephron. Clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/20606479","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15228387","id":"PMC_15228387","title":"Binding of salivary agglutinin to IgA.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15228387","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14631563","id":"PMC_14631563","title":"Pathogenesis of IgA nephropathy.","date":"2003","source":"Seminars in nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/14631563","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17163454","id":"PMC_17163454","title":"The Ig-alpha ITAM is required for efficient differentiation but not proliferation of pre-B cells.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17163454","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10900006","id":"PMC_10900006","title":"The serine and threonine residues in the Ig-alpha cytoplasmic tail negatively regulate immunoreceptor tyrosine-based activation motif-mediated signal transduction.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10900006","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15240688","id":"PMC_15240688","title":"Basal Igalpha/Igbeta signals trigger the coordinated initiation of pre-B cell antigen receptor-dependent processes.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15240688","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8747711","id":"PMC_8747711","title":"The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing.","date":"1995","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/8747711","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9367406","id":"PMC_9367406","title":"IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells.","date":"1997","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9367406","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34664087","id":"PMC_34664087","title":"The microbiome and IgA nephropathy.","date":"2021","source":"Seminars in immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/34664087","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11399911","id":"PMC_11399911","title":"Molecular genetics in IgA nephropathy.","date":"2001","source":"Nephron","url":"https://pubmed.ncbi.nlm.nih.gov/11399911","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14962183","id":"PMC_14962183","title":"The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell development.","date":"2004","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/14962183","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32553243","id":"PMC_32553243","title":"Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy.","date":"2020","source":"Advances in chronic kidney disease","url":"https://pubmed.ncbi.nlm.nih.gov/32553243","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19243813","id":"PMC_19243813","title":"Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.","date":"2009","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19243813","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21355954","id":"PMC_21355954","title":"Overexpression of immunoglobulin (CD79a) binding protein1 (IGBP-1) in small lung adenocarcinomas and its clinicopathological significance.","date":"2011","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/21355954","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17638667","id":"PMC_17638667","title":"CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner.","date":"2007","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17638667","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8562023","id":"PMC_8562023","title":"Genetics of IgA deficiency.","date":"1995","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/8562023","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4055989","id":"PMC_4055989","title":"Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.","date":"1985","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/4055989","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35125382","id":"PMC_35125382","title":"IgA vasculitis nephritis.","date":"2022","source":"Current opinion in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/35125382","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1591006","id":"PMC_1591006","title":"Antigen receptors on B lymphocytes.","date":"1992","source":"Annual review of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1591006","citation_count":437,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2463161","id":"PMC_2463161","title":"B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2463161","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1569106","id":"PMC_1569106","title":"Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1569106","citation_count":287,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1881434","id":"PMC_1881434","title":"The B-cell antigen receptor of the five immunoglobulin classes.","date":"1991","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1881434","citation_count":267,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15174051","id":"PMC_15174051","title":"An investigation into the human serum \"interactome\".","date":"2004","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/15174051","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7539038","id":"PMC_7539038","title":"Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling.","date":"1995","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7539038","citation_count":224,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7500027","id":"PMC_7500027","title":"Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling.","date":"1995","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7500027","citation_count":218,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17374736","id":"PMC_17374736","title":"Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17374736","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14967045","id":"PMC_14967045","title":"Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14967045","citation_count":110,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11449366","id":"PMC_11449366","title":"Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11449366","citation_count":106,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12651942","id":"PMC_12651942","title":"Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a).","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12651942","citation_count":106,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7512031","id":"PMC_7512031","title":"CD5 is associated with the human B cell antigen receptor complex.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7512031","citation_count":103,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21324920","id":"PMC_21324920","title":"Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21324920","citation_count":96,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11909947","id":"PMC_11909947","title":"The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11909947","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24162774","id":"PMC_24162774","title":"The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression.","date":"2013","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24162774","citation_count":84,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10438530","id":"PMC_10438530","title":"Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10438530","citation_count":77,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6196366","id":"PMC_6196366","title":"Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration.","date":"1983","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6196366","citation_count":76,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9183005","id":"PMC_9183005","title":"Prothrombin, albumin and immunoglobulin A form covalent complexes with alpha1-microglobulin in human plasma.","date":"1997","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9183005","citation_count":75,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12886015","id":"PMC_12886015","title":"A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12886015","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8666916","id":"PMC_8666916","title":"Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1.","date":"1996","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8666916","citation_count":72,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9531288","id":"PMC_9531288","title":"Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9531288","citation_count":71,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20237496","id":"PMC_20237496","title":"New genetic associations detected in a host response study to hepatitis B vaccine.","date":"2010","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20237496","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44574,"output_tokens":3692,"usd":0.094551},"stage2":{"model":"claude-opus-4-6","input_tokens":7252,"output_tokens":2856,"usd":0.16149},"total_usd":0.606999,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58432,"output_tokens":8148,"usd":0.148758},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":11245,"output_tokens":3143,"usd":0.2022}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"CD79a (mb-1/Igα) is a component of the B-cell antigen receptor (BCR) complex, physically associated with membrane immunoglobulin, and functions as a signaling subunit transmitting signals after antigen binding; it appears before the pre-B cell stage and can persist through the plasma cell stage.\",\n      \"method\": \"Immunohistochemistry with monoclonal antibody JCB117 on paraffin-embedded tissue sections; B-cell lineage characterization across maturation stages\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — extensively characterized across 454 tissue biopsies with functional context established by multiple prior studies; replicated across institutions\",\n      \"pmids\": [\"7632952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Homozygous splice defect mutations in CD79A (Igα) cause a complete block in B-cell development at the pro-B to pre-B transition, resulting in agammaglobulinemia; CD79a does not play a critical role until expressed as part of the pre-BCR with mu heavy chain, and Igα-deficiency does not affect V-DJ rearrangement diversity.\",\n      \"method\": \"Human patient genetics (homozygous splice defect identification); immunofluorescence comparison of B-cell developmental stages between Igα-deficient and mu heavy chain-deficient patients; V-DJ rearrangement sequencing\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in human patient with defined cellular phenotype and mechanistic comparison, multiple orthogonal methods\",\n      \"pmids\": [\"10525050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Igα/Igβ heterodimer is present on the surface of mu-negative pro-B cells associated with calnexin; cross-linking of Igβ on pro-B cells induces rapid tyrosine phosphorylation of Igα and downstream signaling molecules including Syk, PI3-kinase, Vav, SLP-76, and ERK, and drives differentiation from pro-B to small pre-B cell stage analogous to pre-BCR signaling.\",\n      \"method\": \"Pro-B cell line surface detection; cross-linking assays with anti-Igβ monoclonal antibody on RAG-2-deficient bone marrow pro-B cells; in vivo antibody treatment of RAG-2-deficient mice; tyrosine phosphorylation and MAP kinase activation assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro signaling assays with specific readouts plus in vivo functional rescue, replicated across cell types\",\n      \"pmids\": [\"9354476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Truncation of the Igα intracellular domain (mb-1 delta-c) results in constitutive antigen receptor signaling on immature B cells, causing abnormal activation and loss of transitional immature IgMhigh IgDlow B cells, demonstrating a negative regulatory role for the Igα cytoplasmic tail in antigen receptor signaling during B-cell development.\",\n      \"method\": \"Genetic mouse model (mb-1 delta-c/delta-c knock-in); flow cytometric analysis of B-cell developmental stages; functional signaling studies\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO/KI mouse model with defined cellular phenotype and mechanistic pathway placement\",\n      \"pmids\": [\"10591178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Serine and threonine residues in the Igα cytoplasmic tail negatively regulate ITAM-mediated signal transduction; mutation of these residues to alanine/valine results in stronger tyrosine phosphorylation and increased signaling upon BCR stimulation.\",\n      \"method\": \"Site-directed mutagenesis of Igα serine/threonine residues; expression as single-chain Fv/Igα or in complete BCR context; tyrosine phosphorylation assays upon stimulation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct mutagenesis with functional signaling readout in two expression contexts\",\n      \"pmids\": [\"10900006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Basal (ligand-independent) signaling through non-aggregated Igα/Igβ-containing complexes at the inner plasma membrane leaflet is sufficient to promote proliferation under low IL-7, suppress V(H)(D)J(H) recombination, and induce kappa light chain recombination and cytoplasmic kappa expression in primary pro-B cells, demonstrating that pre-BCR aggregation is not required for Igα/Igβ function.\",\n      \"method\": \"Membrane-targeted surrogate pre-BCR construct (cytoplasmic regions of Igα/Igβ); transmission electron microscopy to assess aggregation state; primary pro-B cell transfection; proliferation, VDJ recombination, and light-chain assays\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution with surrogate receptor plus EM structural analysis plus multiple functional readouts\",\n      \"pmids\": [\"15240688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The Igα ITAM tyrosines (and Y204) are required for efficient pre-B cell differentiation and calcium flux, but not for pre-B cell proliferation; surface IL-7 receptor expression is modulated by the pre-BCR, increasing IL-7 sensitivity of pre-BCR-expressing cells.\",\n      \"method\": \"Reconstitution of individual Igα tyrosine mutants in SLP-65/Igα double-deficient pre-B cells; pre-BCR surface expression analysis; calcium flux assays; proliferation and differentiation assays; IL-7 concentration titration\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with multiple mutants plus orthogonal functional readouts (calcium flux, proliferation, differentiation)\",\n      \"pmids\": [\"17163454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The murine mb-1 gene encoding CD79a (Igα) has a five-exon structure: exon 1 (5' UTR and signal peptide), exon 2 (extracellular domain), exon 3 (transmembrane domain), exon 4 and 5 (cytoplasmic domain and 3'UTR); B cell-specific expression is associated with a DNase I-hypersensitive site in the 3'-flanking region and a decanucleotide sequence homologous to the IgVH octamer motif in the 5'-flanking region.\",\n      \"method\": \"Genomic DNA cloning and sequencing; DNase I hypersensitivity mapping; Southern blot analysis\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct structural characterization of gene with functional regulatory element mapping\",\n      \"pmids\": [\"2358676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The mb-1 gene (encoding Igα/CD79a) is expressed exclusively in B cells beginning at the very early pro-B cell stage in the bone marrow; integration of Cre recombinase into the mb-1 locus (mb1-cre) achieves extraordinarily efficient and pan-B-cell-specific recombination of loxP sites beginning at the pro-B cell stage.\",\n      \"method\": \"Knock-in mouse generation (humanized Cre into mb-1 locus); reporter gene recombination assays (SRp20, Dnmt1); B-cell developmental staging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic tool validation with multiple reporter genes confirming B-cell-specific and pro-B-stage-onset expression\",\n      \"pmids\": [\"16940357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Alternative mRNA splicing of mb-1 generates variant transcripts encoding proteins that retain transmembrane and cytoplasmic portions of Igα but lack extracellular cysteine residues required for disulfide bonds; these variant proteins cannot support BCR expression on cell surfaces; B-cell activation with anti-IgM, LPS, or IL-4 induces increased amounts of variant transcripts.\",\n      \"method\": \"RT-PCR identification of splice variants; transfection studies assessing BCR surface expression; B-cell activation experiments with anti-IgM, LPS, IL-4\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional demonstration by transfection that splice variant cannot form surface BCR, single lab\",\n      \"pmids\": [\"8747711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"IGBP-1 (immunoglobulin binding protein 1) was initially identified as a signal transduction molecule co-precipitating with MB1 (Igα) of the B-cell antigen receptor complex, and was later characterized as a regulatory component of protein phosphatase 2A (PP2A) catalytic subunits.\",\n      \"method\": \"Co-immunoprecipitation with MB1/Igα; biochemical characterization of PP2A association\",\n      \"journal\": \"Pathology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-precipitation identifying binding partner, single method, referenced in secondary paper\",\n      \"pmids\": [\"21355954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In the avian BCR system, the cytoplasmic domain of Igα (CD79a) efficiently supports B-cell development in precursors lacking endogenous surface Ig expression when expressed as a chimeric receptor, whereas the cytoplasmic domain of Igβ actively inhibits B-cell development, demonstrating functionally distinct roles for the two ITAM-containing subunits.\",\n      \"method\": \"Retroviral gene transfer of chimeric CD8α-Igα and CD8α-Igβ cytoplasmic domain constructs into developing B-cell precursors in vivo in the chicken bursa of Fabricius\",\n      \"journal\": \"Immunological reviews\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional rescue experiment in avian ortholog with clean developmental readout, single lab\",\n      \"pmids\": [\"14962183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A composite CD79A/CD40 co-stimulatory endodomain in CD19-CAR T cells induces higher NF-κB and p38 activity upon CD19 antigen exposure compared to CD28 or 4-1BB domains, resulting in enhanced CAR-T cell proliferation, sustained tumor suppression, and superior in vivo anti-tumor activity in a Raji mouse model.\",\n      \"method\": \"CAR-T cell engineering with CD79A/CD40 composite co-stimulatory domain; NF-κB and p38 signaling assays; co-culture cytotoxicity assays; in vivo Raji tumor model in mice; comparison with CD28z and BBz constructs\",\n      \"journal\": \"Molecular therapy : the journal of the American Society of Gene Therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (signaling, in vitro, in vivo) in single lab demonstrating CD79A cytoplasmic domain-mediated NF-κB signaling function\",\n      \"pmids\": [\"33940156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD79a/CD79b (Igα/Igβ) are essential components of the BCR complex that initiate and transduce BCR signals required for normal and malignant B-cell survival; post-translational modifications of CD79a/CD79b (including ITAM tyrosine phosphorylation and serine/threonine phosphorylation) regulate signal integration, and lymphoma-associated mutations in CD79A/CD79B dysregulate these signaling cascades.\",\n      \"method\": \"Review synthesizing data from multiple experimental studies including mutagenesis, Co-IP, signaling assays, and structural analyses\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — comprehensive review integrating multiple prior experimental findings; confidence reflects synthesis rather than new primary data\",\n      \"pmids\": [\"38203179\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD79a (Igα/mb-1) is an essential transmembrane signaling subunit of the B-cell antigen receptor complex that forms a disulfide-linked heterodimer with CD79b (Igβ); its cytoplasmic ITAM tyrosines initiate downstream kinase cascades (Syk, PI3K, Vav, ERK) upon BCR engagement, while serine/threonine phosphorylation of its cytoplasmic tail provides negative regulation of ITAM-mediated signaling; basal Igα/Igβ signals (independent of receptor aggregation) drive pro-B to pre-B differentiation including allelic exclusion and light-chain recombination, whereas truncation of the Igα intracellular domain causes constitutive signaling and a block in B-cell maturation, and complete loss-of-function mutations in humans result in agammaglobulinemia due to arrest at the pro-B to pre-B transition.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper, then extract discoveries only from KEPT papers about CD79A (Igα, mb-1).\n\n**Classification summary:**\n- Papers about IgA nephropathy, IgA immunology, IgA receptors (CD89/FcαRI), secretory IgA biology → EXCLUDE (these are about IgA the antibody, not CD79A/Igα)\n- Papers [59] MB-1 = microalga → EXCLUDE (symbol collision)\n- Papers [95] MB1 = proteasomal subunit → EXCLUDE (symbol collision)\n- Papers about CD79A as a B-cell marker (IHC/flow cytometry) without mechanistic findings → EXCLUDE\n- Papers mechanistically describing CD79A/Igα function → KEEP\n\n**KEPT papers:**\n- [3] PMID:16940357 — mb1-cre mice; mb1 gene encodes Igα signaling subunit\n- [15] PMID:7632952 — CD79a marker description (mostly expression, but notes membrane association and signaling role — borderline; primarily expression/marker, EXCLUDE)\n- [16] PMID:10525050 — Mutations in Igα cause block in B-cell development\n- [26] PMID:9354476 — Igα/Igβ heterodimer on proB cells; cross-linking induces signaling cascade\n- [30] PMID:15492262 — PAX5/CD79a comparative expression study — EXCLUDE (expression/biomarker)\n- [36] PMID:2358676 — mb-1 gene structure, B-cell-specific expression, DNase-hypersensitive site\n- [46] PMID:38203179 — Review of CD79a/CD79b BCR signaling (mechanistic review)\n- [57] PMID:10591178 — Igα cytoplasmic tail truncation; negative regulatory role\n- [66] PMID:33940156 — CD79A/CD40 co-stimulatory domain in CAR-T cells\n- [86] PMID:17163454 — Igα ITAM required for differentiation but not proliferation\n- [87] PMID:10900006 — Serine/threonine residues in Igα tail negatively regulate ITAM signaling\n- [88] PMID:15240688 — Basal Igα/Igβ signals trigger pre-BCR processes\n- [89] PMID:8747711 — Alternative splicing of mb-1; variants cannot constitute BCR\n- [93] PMID:14962183 — Avian Igα cytoplasmic domain supports B-cell development (ortholog)\n- From gene2pubmed:\n  - [8] PMID:1591006 — BCR structure; Igα/Igβ heterodimer association with mIg\n  - [9] PMID:2463161 — mb-1 gene, B-lineage expression, structural properties\n  - [10] PMID:1569106 — PTK72 (Syk) associated with BCR via MB-1\n  - [11] PMID:1881434 — Alpha chain associates with all five Ig classes\n  - [13] PMID:7539038 — PTP1C (SHP-1) associates with BCR; dephosphorylates Igα\n  - [14] PMID:7500027 — Syk SH2 domains required for recruitment to phospho-Igα/Igβ\n  - [17] PMID:14967045 — Igα cytoplasmic domain forms stable dimers/tetramers\n  - [18] PMID:11449366 — SLP-65 associates with Igα via non-ITAM Y204\n  - [19] PMID:12651942 — Somatic hypermutation of mb1/CD79A\n  - [20] PMID:7512031 — CD5 associates with BCR complex including Igα\n  - [21] PMID:21324920 — CD79A mutations in ABC-DLBCL; PKC inhibitor sensitivity\n  - [22] PMID:11909947 — BLNK recruited to Igα via non-ITAM tyrosines Y176/Y204\n  - [27] PMID:12886015 — BAP29/BAP31 retain mIgD in ER; Igα/Igβ competes with BAP complex\n  - [29] PMID:9531288 — Asymmetric phosphorylation of CD79a ITAM tyrosines; N-terminal Y sufficient for signaling\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"The mb-1 gene (encoding Igα/CD79A) was identified as a B lymphocyte lineage-restricted gene encoding a putative membrane glycoprotein with a leader sequence, extracellular domain, transmembrane portion, and intracellular domain. Antibodies against the mb-1 fusion protein stained pre-B and mature B cell lines on their surface but not T cell lines or fibroblasts, establishing its B-cell-specific surface expression.\",\n      \"method\": \"cDNA cloning, Northern blot, antibody staining of cell lines\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original gene identification with protein expression validation, highly cited foundational paper\",\n      \"pmids\": [\"2463161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The murine mb-1 gene structure was characterized: five exons encoding signal peptide, extracellular, transmembrane, and cytoplasmic domains. A B cell-specific DNase I-hypersensitive site was identified in the 3'-flanking region, indicating its involvement in B cell-specific expression of mb-1.\",\n      \"method\": \"Genomic DNA cloning, Southern blot, DNase I hypersensitivity assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct structural characterization of the gene with functional regulatory element identification\",\n      \"pmids\": [\"2358676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"A common Igα (CD79A) chain associates with all five immunoglobulin classes (IgM, IgD, IgG, IgA, IgE) at the B cell surface. Just two proteins—the alpha and beta associated chains—are sufficient to reconstitute an IgM surface receptor in fibroblasts, demonstrating that the Igα/Igβ heterodimer is the minimal signaling unit of the BCR.\",\n      \"method\": \"Reconstitution in fibroblasts, co-immunoprecipitation, surface receptor expression\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution experiment in non-B cells establishing sufficiency; foundational paper\",\n      \"pmids\": [\"1881434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The 72-kDa protein-tyrosine kinase PTK72 (Syk) is physically associated with the B cell antigen receptor via MB-1 (Igα/CD79A). PTK72 co-immunoprecipitates with sIgM, phosphorylates MB-1 in immune complexes, and its enzymatic activity is activated upon cross-linking of sIgM, placing Syk as an Igα-associated kinase that is activated downstream of BCR engagement.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, peptide mapping, reimmunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal co-IP, in vitro phosphorylation, and activation assay in a single study\",\n      \"pmids\": [\"1569106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Cross-linking of the B cell antigen receptor results in rapid tyrosine phosphorylation of substrate proteins, and the BCR is a multicomponent complex in which membrane-bound Ig is noncovalently associated with an Igα/Igβ heterodimer, establishing the structural basis of BCR-mediated signaling analogous to the T cell receptor/CD3 complex.\",\n      \"method\": \"Biochemical co-immunoprecipitation, tyrosine phosphorylation assays\",\n      \"journal\": \"Annual review of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — synthesis of multiple experimental findings; highly cited foundational review summarizing demonstrated mechanisms\",\n      \"pmids\": [\"1591006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CD5 is physically associated with the B cell antigen receptor complex including Igα (CD79A) on human B cells, and CD5 serves as a substrate for BCR-induced tyrosine kinase activity, indicating that CD5+ B cells have a unique capacity to modulate BCR signals.\",\n      \"method\": \"Co-immunoprecipitation, tyrosine phosphorylation assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP study demonstrating BCR-CD5 association\",\n      \"pmids\": [\"7512031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PTP1C (SHP-1) constitutively associates with the resting BCR complex through co-precipitation with BCR components including Igα. PTP1C specifically dephosphorylates a 35-kDa BCR-associated protein likely representing Igα, and dissociates from the activated BCR complex after receptor engagement, revealing SHP-1 as a phosphatase that regulates the tyrosine phosphorylation state of Igα in resting B cells.\",\n      \"method\": \"Co-immunoprecipitation, phosphatase activity assay, anti-PTP1C antibody depletion\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-IP, phosphatase activity, antibody depletion) in motheaten mice and cell lines\",\n      \"pmids\": [\"7539038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Both Syk SH2 domains are required for recruitment of Syk to tyrosine-phosphorylated Igα and Igβ ITAMs, and this recruitment is necessary for BCR-mediated Syk and PLCγ2 phosphorylation, IP3 release, and Ca2+ mobilization. The Syk autophosphorylation site Y518/Y519 is required for signal transduction but not for ITAM binding, indicating that ITAM binding precedes and is required for Syk autophosphorylation.\",\n      \"method\": \"Syk knockout B cells reconstituted with Syk mutants, co-immunoprecipitation, calcium flux assay, PLC-γ2 phosphorylation\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genetic reconstitution with structure-function mutagenesis in knockout cells\",\n      \"pmids\": [\"7500027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Novel variants of mb-1 (CD79A) transcripts generated by alternative mRNA splicing were identified. The variant proteins conserve transmembrane and cytoplasmic portions but lack part of the extracellular domain containing cysteine residues required for disulfide bonds. Transfection studies revealed that variant mb-1 does not contribute to BCR surface expression. B cell activation with anti-IgM, LPS, or IL-4 significantly increases the amount of variant mb-1 transcripts.\",\n      \"method\": \"cDNA cloning, transfection, BCR surface expression assay, Northern blot\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional demonstration by transfection that splice variant cannot form BCR\",\n      \"pmids\": [\"8747711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Igα/Igβ heterodimer is present on the surface of μ-negative proB cell lines in association with calnexin. Cross-linking of Igβ on RAG-2-deficient proB cells induces rapid tyrosine phosphorylation of Igα as well as Syk, PI3-kinase, Vav, SLP-76, and ERK (but not JNK or p38), and induces proB cell differentiation to the small preB cell stage, demonstrating that the Igα/Igβ heterodimer is signaling-competent before μ heavy chain expression.\",\n      \"method\": \"Flow cytometry, anti-Igβ cross-linking in RAG-2-deficient mice, tyrosine phosphorylation analysis, in vivo mAb treatment\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro experiments with defined signaling cascade and developmental readout\",\n      \"pmids\": [\"9354476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Phosphorylation of the two ITAM tyrosines of CD79a (Igα) is asymmetrical: >80% of phosphorylation occurs on the N-terminal tyrosine (Y-E-G-L). Only the N-terminal ITAM tyrosine of CD79a is required for ligand-mediated phosphorylation of the receptor and downstream substrates (p62, p110, Shc), and for Ca2+ mobilization. Both tyrosines are required for Syk phosphorylation. CD79b shows greater dependence on both tyrosines compared to CD79a.\",\n      \"method\": \"MHC class II chimeric receptor system, ITAM tyrosine-to-phenylalanine mutagenesis, phosphorylation assays, Ca2+ mobilization\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with multiple downstream readouts in defined chimeric receptor system\",\n      \"pmids\": [\"9531288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A homozygous splice defect in Igα (CD79A) in a human patient causes a complete block in B-cell development at the pro-B to pre-B transition, equivalent to that seen in μ heavy chain deficiency, establishing CD79A mutations as a cause of agammaglobulinemia. The block occurs after V-DJ rearrangement, suggesting Igα is not critical for development until expressed as part of the pre-BCR with μ heavy chain.\",\n      \"method\": \"Human patient genetic analysis, immunofluorescence of bone marrow B-cell developmental stages, V-DJ sequencing\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function genetics with defined cellular phenotype and comparison to μ-chain deficiency\",\n      \"pmids\": [\"10525050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Truncation of the Igα intracellular cytoplasmic domain (mb-1 Δc/Δc mice) results in constitutive signaling of the antigen receptor complex on immature B cells, causing activation and loss of transitional IgMhigh IgDlow B cells, thereby accounting for the paucity of mature peripheral B cells. This demonstrates a negative regulatory role for the Igα cytoplasmic tail during B cell development.\",\n      \"method\": \"mb-1 cytoplasmic tail truncation knock-in mouse, flow cytometry of B-cell developmental stages, analysis of immature B cell activation\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knock-in mouse with defined cellular phenotype and mechanistic interpretation\",\n      \"pmids\": [\"10591178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"All serine and threonine residues in the Igα cytoplasmic tail were mutated to alanine/valine, resulting in stronger tyrosine phosphorylation of Igα and increased BCR signaling upon stimulation. This establishes that serine/threonine kinases negatively regulate ITAM-mediated signal transduction from the BCR by phosphorylating the Igα tail.\",\n      \"method\": \"Site-directed mutagenesis of all Ser/Thr residues, single-chain Fv/Igα chimera and full BCR context, tyrosine phosphorylation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis in two expression contexts with signaling readout\",\n      \"pmids\": [\"10900006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SLP-65 (BLNK) directly associates with the BCR signaling subunit via the SH2 domain of SLP-65 binding to phosphorylated Igα tyrosine Y204, which is located outside the ITAM. This identifies a non-ITAM phosphorylation site on Igα as a transmembrane adaptor function coupling the BCR to distal signaling pathways.\",\n      \"method\": \"Co-immunoprecipitation after B cell stimulation, SH2-phosphotyrosine interaction mapping\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction demonstrated by co-IP with domain-level specificity\",\n      \"pmids\": [\"11449366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BLNK is directly recruited to Igα via non-ITAM tyrosines Y176 and Y204. Using chimeric receptors with wild-type and mutant Igα cytoplasmic tails, Y204 was shown to bind BLNK directly, and fusion of BLNK to mutated Igα reconstituted downstream signaling. BCR ligation induces Y204 phosphorylation and BLNK recruitment, establishing the molecular mechanism by which Igα couples Syk activation to BLNK-dependent pathways.\",\n      \"method\": \"Chimeric receptor mutagenesis, direct binding assays, reconstitution of signaling in mutant-Igα expressing cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and direct binding, multiple orthogonal methods\",\n      \"pmids\": [\"11909947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The mb-1 (Igα/CD79A) gene undergoes somatic hypermutation (SHM) in germinal center B cells at frequencies similar to other non-Ig genes but lower than Ig genes. Mutations in mb-1 occur as single nucleotide substitutions targeted to hotspots, with a characteristic distribution pattern across the gene, identifying CD79A as a target of the SHM machinery during B cell maturation.\",\n      \"method\": \"Sequencing of mb-1 genes from GC-derived malignant B cell lines and normal peripheral B cells, SHM hotspot analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct sequencing across multiple normal and malignant B cell samples with statistical analysis\",\n      \"pmids\": [\"12651942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BAP29 and BAP31 ER-resident membrane proteins bind to membrane-bound IgD in the ER and retain it there; this retention is distinct from and competitive with Igα/Igβ binding to mIgD. Only a minor fraction of intracellular mIgD is associated with BAP29/BAP31 complexes. Coexpression of BAP29/BAP31 prevented aberrant surface transport of mIgD in the absence of Igα/Igβ, establishing that BAP complexes function as ER retention proteins for mIg that is not assembled with Igα/Igβ.\",\n      \"method\": \"Blue native PAGE, co-immunoprecipitation, Drosophila S2 cell surface expression, chimeric mIgD constructs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including reconstitution in non-B cells\",\n      \"pmids\": [\"12886015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The cytoplasmic domain of Igα (CD79A) forms stable dimers and tetramers in solution even below 10 μM, in contrast to other ITAM-containing proteins. Circular dichroic analysis reveals that the Igα cytoplasmic domain lacks stable ordered structure (random-coil-like), and phosphorylation does not significantly alter oligomerization behavior, suggesting a structural basis for transmembrane signal initiation.\",\n      \"method\": \"Purified recombinant Igα cytoplasmic domain, biophysical assays (sedimentation, CD spectroscopy), NMR, phosphorylation analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods with purified recombinant protein\",\n      \"pmids\": [\"14967045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Basal signaling through non-aggregated Igα/Igβ complexes targeted to the inner plasma membrane leaflet of primary pro-B cells is sufficient to promote pre-BCR-dependent processes: enhanced proliferation at low IL-7, suppression of VH(D)JH recombination, and induction of κ light chain recombination and cytoplasmic κ expression. This demonstrates that pre-BCR aggregation is not required for pre-BCR function and that tonic Igα/Igβ signals coordinate developmental checkpoints.\",\n      \"method\": \"Membrane-targeted cytoplasmic Igα/Igβ construct in primary pro-B cells, IL-7 proliferation assay, VDJ/κ recombination analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic reconstitution in primary cells with multiple developmental readouts\",\n      \"pmids\": [\"15240688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The cytoplasmic domain of avian Igα (CD79A ortholog) efficiently supports B-cell development in precursors lacking endogenous sIg when expressed as a chimeric CD8α-Igα(cyt) receptor, whereas an equivalent chimeric receptor containing the Igβ cytoplasmic domain actively inhibited B-cell development. This establishes functionally distinct roles for the Igα and Igβ cytoplasmic domains in B-cell development.\",\n      \"method\": \"Retroviral gene transfer of chimeric receptor constructs into chicken B-cell precursors in vivo, B-cell development assay\",\n      \"journal\": \"Immunological reviews\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic reconstitution with defined developmental readout\",\n      \"pmids\": [\"14962183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The mb-1 gene (encoding Igα/CD79A) was used as a host locus for Cre recombinase to generate mb1-cre mice. Integration of humanized Cre into the mb1 locus results in extraordinarily efficient recombination of loxP sites exclusively in the B cell lineage beginning at the very early pro-B cell stage, confirming that mb-1/CD79A expression initiates at the earliest B-cell progenitor stage.\",\n      \"method\": \"Knock-in of humanized Cre into mb1 locus, reporter gene analysis across B-cell developmental stages\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knock-in with multiple reporter validations across stages\",\n      \"pmids\": [\"16940357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The Igα ITAM is required for efficient pre-B cell differentiation but not for pre-BCR-induced proliferation. Reconstitution of Igα tyrosine mutants in SLP-65/Igα double-deficient pre-B cells showed comparable pre-BCR surface expression but different signaling (tyrosine phosphorylation, calcium flux); the ITAM tyrosines and Y204 are required for efficient calcium flux and differentiation. Additionally, the pre-BCR modulates IL-7 receptor surface expression, increasing IL-7 sensitivity.\",\n      \"method\": \"Igα mutant reconstitution in double-deficient pre-B cells, proliferation and differentiation assays, calcium flux, flow cytometry\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic mutagenesis with functional reconstitution and multiple readouts\",\n      \"pmids\": [\"17163454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Anti-CD79b antibody-drug conjugates (ADCs) are trafficked to the lysosomal-like MHC class II-positive compartment (MIIC) following BCR internalization. Anti-CD79b ADCs with stable linkers were effective in killing NHL cell lines in vitro and in xenograft models. Anti-CD79b ADCs downregulated surface BCR, while anti-CD79a ADCs were less effective, suggesting differential intracellular trafficking between CD79a and CD79b upon BCR engagement.\",\n      \"method\": \"ADC cytotoxicity assays in NHL cell lines, xenograft mouse models, confocal microscopy of lysosomal trafficking, BCR downregulation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct trafficking/localization experiments with functional consequence, but CD79a role is comparative/secondary\",\n      \"pmids\": [\"17374736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CD79A/CD79B mutations in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) correlate with sensitivity to the PKC inhibitor sotrastaurin (STN). PKC inhibition in CD79A/B-mutant cells blocks NF-κB pathway activity, induces G1-phase cell-cycle arrest and/or cell death, and produces significant antitumor effects in a xenograft model, establishing that CD79A mutations drive constitutive NF-κB activation via PKC-dependent BCR signaling.\",\n      \"method\": \"Cell line sensitivity profiling, NF-κB pathway analysis, cell cycle assay, xenograft mouse model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (biochemical, cellular, in vivo) with genetic stratification\",\n      \"pmids\": [\"21324920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A composite CD79A/CD40 co-stimulatory endodomain incorporated into CD19-CAR T cells (CD19.79a.40z) induces higher NF-κB and p38 activity upon CD19 antigen exposure compared to CD28 or 4-1BB co-stimulatory domains. CD19.79a.40z CAR-T cells exhibit robust T cell proliferation independent of exogenous IL-2, sustained tumor suppression in co-culture, and superior anti-tumor activity with enhanced in vivo CAR-T cell proliferation in Raji-inoculated mice, demonstrating that the CD79A intracellular domain can activate NF-κB signaling and enhance T cell function as a co-stimulatory module.\",\n      \"method\": \"CAR-T cell co-culture cytotoxicity assays, NF-κB/p38 reporter assays, in vitro proliferation, Raji xenograft mouse model\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro and in vivo methods with mechanistic NF-κB pathway analysis\",\n      \"pmids\": [\"33940156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD79a/CD79b mediate BCR signal initiation and transduction through ITAMs, with post-translational modifications (phosphorylation of ITAM tyrosines, serine/threonine phosphorylation) regulating signaling. CD79A/CD79B mutations in lymphoid neoplasms, particularly ABC-DLBCL, cause constitutive BCR signaling through chronic active BCR signaling. CD79a functions as a signal integrator within the BCR complex, with its non-ITAM tyrosines (Y176, Y204) serving as adaptor sites for BLNK/SLP-65 recruitment, and its cytoplasmic tail regulating signal amplitude through serine/threonine phosphorylation.\",\n      \"method\": \"Review synthesizing ITAM mutagenesis, structural, interactome, and lymphoma mutation studies\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — comprehensive mechanistic review, no new primary data; supports existing findings\",\n      \"pmids\": [\"38203179\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD79A (Igα/mb-1) is a B-cell-specific transmembrane protein that forms an obligate Igα/Igβ heterodimer constitutively associated with all classes of membrane-bound immunoglobulin to form the B cell antigen receptor (BCR); upon BCR engagement, Igα ITAM tyrosines are asymmetrically phosphorylated (predominantly at the N-terminal tyrosine) by Src-family kinases and recruit Syk via its dual SH2 domains, while the non-ITAM tyrosine Y204 serves as a direct docking site for the adaptor BLNK/SLP-65 to couple Syk to downstream Ca2+ and NF-κB signaling; the Igα cytoplasmic tail additionally undergoes serine/threonine phosphorylation that negatively regulates ITAM-mediated signaling, and the tail forms stable oligomers in solution; basal tonic Igα/Igβ signaling drives pre-BCR developmental checkpoints including allelic exclusion and light chain recombination without requiring receptor aggregation, while loss-of-function mutations in CD79A cause a complete block in B-cell development at the pro-B to pre-B transition (human agammaglobulinemia), and gain-of-function/chronic-active mutations in the ITAM region drive constitutive NF-κB activation in ABC-DLBCL.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD79A (Igα/mb-1) is the principal signal-transducing subunit of the B-cell antigen receptor (BCR) complex, coupling surface immunoglobulin engagement to intracellular kinase cascades that govern B-cell development, activation, and survival. Expressed exclusively in the B-cell lineage from the earliest pro-B cell stage, CD79A forms a disulfide-linked heterodimer with CD79B (Igβ) that is present on the surface even before membrane immunoglobulin expression, where cross-linking triggers ITAM tyrosine phosphorylation and activation of Syk, PI3K, Vav, and ERK; basal (ligand-independent) signaling through non-aggregated Igα/Igβ complexes is sufficient to suppress VH rearrangement, induce light-chain recombination, and drive pro-B to pre-B differentiation [PMID:9354476, PMID:15240688, PMID:17163454]. Serine/threonine residues in the Igα cytoplasmic tail negatively regulate ITAM-mediated signaling, and truncation of this domain causes constitutive BCR activation and a developmental block at the transitional immature B-cell stage [PMID:10900006, PMID:10591178]. Homozygous loss-of-function mutations in human CD79A cause agammaglobulinemia due to complete arrest at the pro-B to pre-B transition [PMID:10525050].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Determining the genomic architecture of mb-1 (CD79A) established that B-cell-specific expression is controlled by a 5′ octamer-like motif and a 3′ DNase I-hypersensitive site, providing the first structural framework for understanding lineage-restricted transcription of this gene.\",\n      \"evidence\": \"Genomic cloning, sequencing, and DNase I hypersensitivity mapping of the murine mb-1 locus\",\n      \"pmids\": [\"2358676\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise transcription factors binding the regulatory elements were not identified\", \"No functional reporter assays to test sufficiency of these elements\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating CD79A protein expression across B-cell maturation stages—from pro-B cells through plasma cells—and its physical association with membrane immunoglobulin established it as a constitutive BCR signaling subunit rather than a stage-restricted accessory.\",\n      \"evidence\": \"Immunohistochemistry with monoclonal antibody JCB117 on 454 paraffin-embedded tissue biopsies spanning B-cell developmental stages; identification of alternatively spliced transcripts lacking extracellular cysteines that cannot support surface BCR expression\",\n      \"pmids\": [\"7632952\", \"8747711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the splice variants on signaling in vivo was not determined\", \"Quantitative ratio of full-length to variant transcripts at each developmental stage was not established\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showing that Igα/Igβ heterodimers exist on the surface of μ-negative pro-B cells associated with calnexin, and that their cross-linking activates Syk, PI3K, Vav, and ERK to drive pro-B to pre-B differentiation, revealed that CD79A transduces differentiation signals even in the absence of conventional membrane immunoglobulin.\",\n      \"evidence\": \"Surface detection on pro-B cell lines; anti-Igβ cross-linking on RAG-2-deficient bone marrow pro-B cells with tyrosine phosphorylation and MAP kinase assays; in vivo antibody treatment of RAG-2-deficient mice\",\n      \"pmids\": [\"9354476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the calnexin-associated complex on pro-B cells beyond Igα/Igβ was not fully resolved\", \"Whether Igα versus Igβ contribute equally to downstream kinase activation was not dissected\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Two complementary findings—human loss-of-function mutations causing agammaglobulinemia and a mouse knock-in truncating the Igα cytoplasmic domain causing constitutive signaling—established that the Igα intracellular domain is both required for B-cell development and serves as a negative regulator of BCR signal amplitude.\",\n      \"evidence\": \"Human patient homozygous splice defect with developmental block at pro-B to pre-B; mb-1Δc/Δc knock-in mice showing constitutive signaling and loss of transitional immature B cells\",\n      \"pmids\": [\"10525050\", \"10591178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cytoplasmic residues mediating the negative regulatory function had not yet been mapped\", \"Mechanism by which the truncated tail causes constitutive rather than ablated signaling was not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of serine/threonine residues in the Igα cytoplasmic tail as negative regulators of ITAM tyrosine phosphorylation resolved how the same domain could both initiate and attenuate BCR signaling.\",\n      \"evidence\": \"Site-directed mutagenesis of Igα serine/threonine residues to alanine/valine; tyrosine phosphorylation assays in single-chain Fv/Igα and complete BCR contexts\",\n      \"pmids\": [\"10900006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinases responsible for serine/threonine phosphorylation of Igα were not identified\", \"In vivo developmental consequences of individual serine/threonine mutations were not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that non-aggregated, membrane-tethered Igα/Igβ cytoplasmic domains deliver basal signals sufficient for proliferation, light-chain recombination, and allelic exclusion established that pre-BCR aggregation is dispensable for key developmental transitions.\",\n      \"evidence\": \"Membrane-targeted surrogate pre-BCR constructs in primary pro-B cells; transmission electron microscopy confirming monomeric state; proliferation, VDJ recombination, and κ light-chain expression assays\",\n      \"pmids\": [\"15240688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether basal signaling uses the same downstream adaptor complexes as aggregation-induced signaling was not determined\", \"Quantitative threshold of basal signal required for each developmental outcome was not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"In vivo reconstitution in the avian system showed that the Igα cytoplasmic domain positively supports B-cell development whereas the Igβ cytoplasmic domain actively inhibits it, establishing functional non-equivalence of the two BCR ITAM subunits.\",\n      \"evidence\": \"Retroviral chimeric CD8α-Igα and CD8α-Igβ constructs transduced into developing B-cell precursors in the chicken bursa of Fabricius\",\n      \"pmids\": [\"14962183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generalizability to mammalian B-cell development was not formally tested\", \"Molecular basis for the inhibitory function of the Igβ cytoplasmic domain was not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Systematic reconstitution of individual Igα ITAM tyrosine mutants demonstrated that these residues are required for pre-B cell differentiation and calcium signaling but dispensable for proliferation, separating proliferative and differentiative arms of pre-BCR signaling.\",\n      \"evidence\": \"Reconstitution of Igα tyrosine mutants in SLP-65/Igα double-deficient pre-B cells; calcium flux, proliferation, and differentiation assays; IL-7 receptor surface expression analysis\",\n      \"pmids\": [\"17163454\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific adaptor proteins recruited by individual ITAM tyrosines during differentiation versus proliferation were not mapped\", \"Role of Y204 relative to the canonical ITAM tyrosines requires further dissection\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Engineering the CD79A cytoplasmic domain into a CAR-T co-stimulatory endodomain demonstrated that Igα signaling activates NF-κB and p38 pathways in T cells, extending the functional relevance of CD79A signaling beyond B-cell biology.\",\n      \"evidence\": \"CD79A/CD40 composite co-stimulatory domain in CD19-CAR T cells; NF-κB and p38 signaling assays; in vitro co-culture and in vivo Raji tumor model\",\n      \"pmids\": [\"33940156\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CD79A signaling motifs operate identically in T cells and B cells is not established\", \"Long-term safety and persistence of CD79A-domain CAR-T cells not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinases that phosphorylate serine/threonine residues in the Igα tail, the structural basis of basal versus aggregation-induced signaling through the Igα/Igβ heterodimer, and the precise mechanism by which lymphoma-associated CD79A mutations dysregulate BCR signaling thresholds.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Structural model of the Igα/Igβ heterodimer in membrane context is lacking\", \"Serine/threonine kinases targeting Igα remain unidentified\", \"Quantitative relationship between CD79A mutation burden and signaling output in lymphoma is not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 5, 6]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 4, 6, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 5, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [2, 4, 6, 12]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 5, 6, 11]}\n    ],\n    \"complexes\": [\n      \"B-cell antigen receptor (BCR) complex\",\n      \"pre-BCR complex\"\n    ],\n    \"partners\": [\n      \"CD79B\",\n      \"SYK\",\n      \"PIK3CA\",\n      \"VAV1\",\n      \"SLP76\",\n      \"CANX\",\n      \"IGBP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"CD79A (Igα/mb-1) is a B-cell-lineage-restricted transmembrane glycoprotein that heterodimerizes with CD79B (Igβ) to form the obligate signaling subunit of the B-cell antigen receptor (BCR), associating with all five classes of membrane-bound immunoglobulin to transduce antigen-dependent and tonic signals essential for B-cell development and activation [PMID:1881434, PMID:9354476]. Upon BCR engagement, Src-family kinases asymmetrically phosphorylate the Igα ITAM — predominantly at the N-terminal tyrosine — enabling dual-SH2-domain recruitment and activation of Syk, which in turn drives PLCγ2/Ca²⁺ mobilization, while a non-ITAM tyrosine (Y204) directly recruits the adaptor BLNK/SLP-65 to couple Syk to downstream NF-κB and MAPK pathways [PMID:9531288, PMID:11909947, PMID:7500027]. Serine/threonine phosphorylation of the Igα cytoplasmic tail negatively regulates ITAM signaling amplitude, and truncation of this tail causes constitutive signaling and developmental arrest of transitional B cells [PMID:10900006, PMID:10591178]. Homozygous loss-of-function mutations in CD79A cause human agammaglobulinemia with a complete block at the pro-B to pre-B transition, whereas gain-of-function ITAM mutations in ABC-DLBCL drive constitutive NF-κB activation [PMID:10525050, PMID:21324920].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Identification of mb-1 as a B-cell-specific surface glycoprotein gene resolved the question of which lineage-restricted transmembrane molecules might couple surface immunoglobulin to intracellular signaling.\",\n      \"evidence\": \"cDNA cloning with antibody staining of pre-B and mature B cell lines vs. T cells and fibroblasts\",\n      \"pmids\": [\"2463161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No signaling function yet demonstrated\", \"Heterodimeric partner (Igβ) not yet identified in this study\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Reconstitution of surface IgM expression in fibroblasts with only Igα and Igβ established that this heterodimer is the minimal signaling unit of the BCR and associates with all five immunoglobulin isotypes, resolving the composition of the BCR signaling module.\",\n      \"evidence\": \"Fibroblast reconstitution with co-immunoprecipitation across IgM/IgD/IgG/IgA/IgE\",\n      \"pmids\": [\"1881434\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase(s) responsible for signal initiation not yet identified\", \"No structural data on Igα/Igβ heterodimer\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Discovery that the tyrosine kinase Syk physically associates with Igα and is activated upon BCR cross-linking identified the first kinase in the Igα proximal signaling cascade, establishing a direct kinase–ITAM connection.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, in vitro kinase assay, and peptide mapping in B cell lines\",\n      \"pmids\": [\"1569106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which ITAM tyrosines are required for Syk binding not yet resolved\", \"Downstream substrates of Syk in this context unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstration that both Syk SH2 domains are required for ITAM binding and that ITAM recruitment precedes Syk autophosphorylation and Ca²⁺ mobilization established the ordered activation mechanism of BCR proximal signaling, while parallel work showed SHP-1 constitutively associates with resting BCR to restrain Igα phosphorylation.\",\n      \"evidence\": \"Syk-knockout B cells reconstituted with SH2/kinase mutants; SHP-1 co-IP with phosphatase activity assays in motheaten mice\",\n      \"pmids\": [\"7500027\", \"7539038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dual SH2–ITAM engagement not resolved\", \"Identity of kinase initially phosphorylating the ITAM not established\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Finding that the Igα/Igβ heterodimer is expressed on pro-B cells before μ heavy chain and can signal through Syk/PI3K/Vav to drive differentiation revealed that Igα has signaling functions independent of complete BCR assembly.\",\n      \"evidence\": \"Anti-Igβ cross-linking on RAG-2-deficient pro-B cells with phosphorylation cascade analysis and in vivo differentiation\",\n      \"pmids\": [\"9354476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Igα or Igβ tail is the dominant contributor to these pre-BCR-independent signals not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Systematic ITAM tyrosine mutagenesis revealed that phosphorylation of the Igα ITAM is asymmetric, with the N-terminal tyrosine (YEGL) accounting for >80% of phosphorylation and being sufficient for most downstream signaling except full Syk activation, which requires both tyrosines.\",\n      \"evidence\": \"MHC class II chimeric receptor system with Y→F point mutations, phosphorylation assays, Ca²⁺ mobilization\",\n      \"pmids\": [\"9531288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural explanation for asymmetric phosphorylation unknown\", \"Kinase selectivity for N- vs. C-terminal ITAM tyrosine not identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"A human homozygous CD79A splice mutation causing complete B-cell developmental arrest at the pro-B/pre-B transition established CD79A as a causative gene for agammaglobulinemia, while truncation of the Igα cytoplasmic tail in mice paradoxically caused constitutive BCR signaling and loss of transitional B cells, revealing a dual role as both activator and negative regulator.\",\n      \"evidence\": \"Human patient genetics with bone marrow staging; mb-1Δc/Δc knock-in mice with flow cytometric B-cell profiling\",\n      \"pmids\": [\"10525050\", \"10591178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which tail truncation causes constitutive signaling not molecularly defined\", \"Additional human CD79A mutations not yet cataloged\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mutation of all serine/threonine residues in the Igα tail to alanine/valine augmented ITAM tyrosine phosphorylation, identifying Ser/Thr phosphorylation as a dedicated negative-feedback mechanism that attenuates BCR signal amplitude.\",\n      \"evidence\": \"Comprehensive S/T→A/V mutagenesis in single-chain Fv/Igα chimera and full BCR, tyrosine phosphorylation readout\",\n      \"pmids\": [\"10900006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Ser/Thr kinase(s) responsible not determined\", \"Stoichiometry and temporal order of Ser/Thr vs. Tyr phosphorylation unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of Y204 as a non-ITAM phosphotyrosine docking site for the SH2 domain of BLNK/SLP-65 revealed how Igα couples proximal Syk activation to distal Ca²⁺ and NF-κB pathways, expanding Igα function beyond classical ITAM signaling.\",\n      \"evidence\": \"Co-immunoprecipitation after BCR stimulation with SH2–phosphotyrosine mapping; confirmed by chimeric receptor mutagenesis and BLNK fusion reconstitution\",\n      \"pmids\": [\"11449366\", \"11909947\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Y176 also recruits BLNK independently of Y204 not fully resolved\", \"No crystal structure of Igα tail–BLNK SH2 complex\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Tonic (non-aggregated) Igα/Igβ signals targeted to the inner plasma membrane suffice to drive pre-BCR-dependent developmental checkpoints including κ light chain recombination, establishing that pre-BCR aggregation is dispensable and basal signaling coordinates allelic exclusion.\",\n      \"evidence\": \"Membrane-targeted cytoplasmic Igα/Igβ construct in primary pro-B cells with IL-7 proliferation, VDJ, and κ recombination readouts\",\n      \"pmids\": [\"15240688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise signaling threshold distinguishing tonic from activated BCR signaling unknown\", \"Which downstream pathways are differentially engaged by tonic vs. aggregated signals not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"CD79A ITAM mutations in ABC-DLBCL were linked to constitutive NF-κB activation and sensitivity to PKC inhibition, establishing a pathogenic gain-of-function mechanism and revealing that oncogenic BCR signaling requires PKC-dependent NF-κB transduction.\",\n      \"evidence\": \"Cell line sensitivity profiling, NF-κB pathway analysis, cell cycle arrest assays, and xenograft models stratified by CD79A/B mutation status\",\n      \"pmids\": [\"21324920\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD79A and CD79B mutations are functionally equivalent or additive not fully dissected\", \"Mechanism by which ITAM mutations escape negative regulation not structurally resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the high-resolution structure of the Igα/Igβ heterodimer and its interface with membrane immunoglobulin, the identity of the Ser/Thr kinases that negatively regulate the Igα tail, and the structural basis for asymmetric ITAM tyrosine phosphorylation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No atomic-resolution structure of the complete BCR signaling complex\", \"Ser/Thr kinase(s) targeting the Igα cytoplasmic tail remain unidentified\", \"Mechanism of Igα cytoplasmic domain oligomerization and its functional significance in vivo not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [14, 15, 25]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 4, 10, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 9, 19]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 7, 10, 14, 15, 24, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 10, 13, 24, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 11, 12, 19, 20, 22]}\n    ],\n    \"complexes\": [\n      \"B-cell antigen receptor (BCR) complex\"\n    ],\n    \"partners\": [\n      \"CD79B\",\n      \"SYK\",\n      \"PTPN6\",\n      \"BLNK\",\n      \"CD5\",\n      \"BCAP31\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}